오미자 물 추출물이 파골세포 분화에 미치는 영향
Effect of Water Extract of Schisandra Chinensis on Osteoclast Differentiation
2
조회
0
다운로드
13
인용
0
참고문헌
키워드
초록
Bone maintains its homeostasis through balance between bone resorbing osteoclasts and bone forming osteoblasts. Thus, unusual balance between osteoclasts and osteoblasts leads to pathological bone diseases, such as osteoporosis, rheumatoid arthritis, autoimmune arthritis, periodontitis. Schisandra chinensis well known traditional herbal has been used for treatment of diseases in China, Korea, Japan, andothers. Recently, research studies have demonstrated that the lignans found in Schisandra chinensis stimulate osteoblasts and suggest that it may be helpful against osteoporosis. However, the inhibitory effect of water extract of Schisandra chinensis on osteoclast differentiation remains largely unknown. In this study, Water extract of Schisandra chinensis markedly suppressed RANKL-induced osteoclast differentiation in cultures of BMMs without cytotoxicity. The mRNA expression of c-Fos, NFATc1, and TRAP induced by RANKL was inhibited by water extract of Schisandra chinensis. It also suppressed c-Fos and NFATc1 protein expression. Taken together, these results suggest that water extract of Schisandra chinensis has the potential to serve as a treatment of bone disease such as osteoporosis.
Abstract
Bone maintains its homeostasis through balance between bone resorbing osteoclasts and bone forming osteoblasts. Thus, unusual balance between osteoclasts and osteoblasts leads to pathological bone diseases, such as osteoporosis, rheumatoid arthritis, autoimmune arthritis, periodontitis. Schisandra chinensis well known traditional herbal has been used for treatment of diseases in China, Korea, Japan, andothers. Recently, research studies have demonstrated that the lignans found in Schisandra chinensis stimulate osteoblasts and suggest that it may be helpful against osteoporosis. However, the inhibitory effect of water extract of Schisandra chinensis on osteoclast differentiation remains largely unknown. In this study, Water extract of Schisandra chinensis markedly suppressed RANKL-induced osteoclast differentiation in cultures of BMMs without cytotoxicity. The mRNA expression of c-Fos, NFATc1, and TRAP induced by RANKL was inhibited by water extract of Schisandra chinensis. It also suppressed c-Fos and NFATc1 protein expression. Taken together, these results suggest that water extract of Schisandra chinensis has the potential to serve as a treatment of bone disease such as osteoporosis.
참고문헌 (25)
- Rodan, G.A, "Therapeutic approaches to bone diseases", Science, 289(5484), pp.1508~1541 (2000)
- Delmas, P.D, "The use of bisphosphonates in the treatment of osteoporosis", Curr Opin Rheumatol, 17(4), pp.462~466 (2005)
- Roodman, G.D, "Regulation of osteoclast differentiation", Ann N Y Acad Sci, 1068, pp.100~109 (2006)
- Teitelbaum, S.L, "Genetic regulation of osteoclast development and function", Nat Rev Genet, 4(8), pp.638~649 (2003)
- Takayanagi, H, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7(4), pp.292~304 (2007)
- 곽한복, "녹용 물 추출물의 파골세포 분화 억제효과", 동의생리병리학회지, 22(4), pp.891~895 (2008), 대한동의병리학회
- Guo, L.Y, "Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill", Eur J Pharmacol, 591(1), pp.293~299 (2008)
- Wagner, E.F, "Genentic control of skeletal development", Curr Opin Genet, 11, pp.527~532 (2001)
- Wagner, E.F, "Reaching a genetic and molecular understanding of skeletal development", Cell, 4, pp.389~406 (2002)
- Hancke, J.L, "Schisandra chinensis (Turcz.)", Baill. Fitoterapia, 70, pp.451~471 (1999)
- Wagner, H, "Chinese drug monographs and analysis: Fructus Schisandrae", Wuweizi, 1, pp.1~8 (1996)
- Caichompoo, W, "Optimization of extraction and purification of active fractions from Schisandra chinensis (Turcz.) and its osteoblastic proliferation stimulating activity", Phytother Res, 23(2), pp.289~292 (2009)
- Nishikawa, M, "Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures", Bone, 18, pp.9~14 (1996)
- Khosla, S, "Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 22, pp.1479~1491 (2007)
- Stacchiotti, A, "Schisandrin B stimulates a cytoprotective response in rat liver exposed to mercuric chloride", Food Chem Toxicol, 47(11), pp.2834~2840 (2009)
- Min, H.Y, "Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells", Bioorg Med Chem Lett, 18(2), pp.523~526 (2008)
- Boyle, W.J, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Takayanagi, H, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7(4), pp.292~304 (2007)
- Takayanagi, H, "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
- Fleischmann, A, "Fra-1 replaces c-Fos-dependent functions in mice", Genes Dev, 14, pp.2695~2700 (2000)
- Takayanagi, H, "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
- Darnay, B.G, "Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappaB and c-Jun N-terminal kinase", J Biol Chem, 273, pp.20551~20555 (1998)
- Wong, B.R, "The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor", J Biol Chem, 273, pp.28355~28359 (1998)
- Takayanagi, H, "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
- Partington, G.A, "Mitf-PU. 1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation", Bone, 34, pp.237~245 (2004)